PubRank

Murali Chintagumpala

Author PubWeight™ 79.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006 6.92
2 Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006 5.96
3 Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005 2.34
4 Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 2004 2.16
5 Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol 2008 1.87
6 Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys 2008 1.76
7 Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells 2008 1.64
8 Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002 1.59
9 Implications of tumor location on subtypes of medulloblastoma. Pediatr Blood Cancer 2013 1.57
10 Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 2005 1.49
11 Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol 2005 1.46
12 Acquired von Willebrand syndrome and Wilms tumor: not always benign. Pediatr Blood Cancer 2009 1.45
13 Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 2006 1.38
14 Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004 1.34
15 Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res 2006 1.31
16 A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol 2010 1.24
17 Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther 2010 1.23
18 Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clin Cancer Res 2013 1.20
19 Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma. Mol Cancer Res 2008 1.16
20 Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 2005 1.12
21 Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med 2009 1.12
22 Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res 2005 1.09
23 FOXG1 dysregulation is a frequent event in medulloblastoma. J Neurooncol 2007 1.08
24 Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet 2003 1.05
25 Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2008 1.02
26 Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor. J Clin Oncol 2004 1.02
27 Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics 2006 1.02
28 White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 2004 1.02
29 Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer 2009 1.01
30 A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol 2010 1.00
31 Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol 2008 0.99
32 Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol 2007 0.95
33 Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. Neuro Oncol 2013 0.95
34 Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol 2011 0.94
35 Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 2010 0.93
36 A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol 2007 0.91
37 Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival. J Neurooncol 2007 0.91
38 Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report. J Neurosurg 2007 0.90
39 Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer 2010 0.89
40 Prenatal presentation and outcome of children with pleuropulmonary blastoma. J Pediatr Surg 2006 0.88
41 Plasma proteome predicts chemotherapy response in osteosarcoma patients. Oncol Rep 2010 0.87
42 Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys 2008 0.87
43 Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys 2012 0.87
44 High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer 2010 0.86
45 Lesion regression. J Neurosurg 2007 0.86
46 Sinonasal teratocarcinosarcoma in an adolescent male. J Pediatr Hematol Oncol 2012 0.85
47 Targeted therapy in bone and soft tissue sarcoma in children and adolescents. Curr Oncol Rep 2012 0.85
48 Long-term outcome of centrally located low-grade glioma in children. Cancer 2013 0.84
49 Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). J Neurooncol 2012 0.83
50 Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol 2011 0.83
51 Elevated expression of CXC chemokines in pediatric osteosarcoma patients. Cancer 2010 0.83
52 Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer 2013 0.83
53 Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer 2012 0.82
54 Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation. J Neurosurg Pediatr 2009 0.80
55 Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997. Pediatr Blood Cancer 2008 0.80
56 Retinoblastoma: from bench to bedside. Expert Rev Mol Med 2003 0.80
57 Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys 2008 0.79
58 Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med 2012 0.79
59 Leukaemia & cancer in neonates. Semin Fetal Neonatal Med 2012 0.79
60 Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience. Hum Pathol 2013 0.78
61 Medulloblastoma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors in a child: case report. J Neurosurg Pediatr 2010 0.77
62 Low-grade myofibroblastic sarcoma of the sacrum. J Neurosurg Pediatr 2010 0.77
63 Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes. Acta Neuropathol Commun 2014 0.77
64 Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 2006 0.77
65 Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma. Pediatr Blood Cancer 2013 0.77
66 Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nat Genet 2015 0.77
67 Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol 2012 0.76
68 Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol 2013 0.75
69 Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. Pediatr Blood Cancer 2011 0.75
70 Neuroendocrine Tumor of the Appendix in Children. J Pediatr Hematol Oncol 2017 0.75
71 Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma. Pediatr Hematol Oncol 2014 0.75
72 Myofibroma in Infancy and Childhood. J Pediatr Hematol Oncol 2017 0.75
73 Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas. J Neurooncol 2014 0.75